Dry Powder Inhaler (DPI)

Aptar CSP Technologies has extensive experience protecting sensitive products, including Active Pharmaceutical Ingredients (APIs) in Dry Powder Inhalers (DPI) and other drug delivery devices.

Our solutions have a track record of success in utilizing patented Activ-PolymerTM technology to absorb moisture, oxygen and volatile organic compounds that can compromise product integrity and stability. Aptar CSP also has proven expertise engineering designs with moisture-tight seals to minimize moisture ingress in high temperature and relative humidity conditions.

Working with Aptar CSP Technologies, Inc., Simplified Solutions was able to develop the XHaler™ device. Simple and efficient, the design was achieved by utilizing a patented technique that opens the protective seal covering the dose to be inhaled. This solution eliminates the need to puncture the protective seal. By removing this step, the risk of contaminating the medical substance with foreign debris is eliminated.

Utilizing Aptar CSP Technologies’ patented, three-phase Activ-Polymer™ technology, XHaler™ offers unrivaled moisture protection coupled with excellent performance. XHaler™ incorporates moisture protection, dose counting, and key safety features together with inspiring industrial design to create a world-class inhaler platform for your drug formulation.

Benefits

  • Seamless integration – integrate Activ-PolymerTM technology into functional components
  • Sophistication – innovative multi-shot components including in-mold assembly and in-mold labeling
  • Design flexibility – ability to combine multiple components into one integrated part to meet space constraints
  • Reduced cost – streamlined design reduces complexity and improves the robustness of assembly operations